226
Participants
Start Date
March 6, 2023
Primary Completion Date
April 24, 2026
Study Completion Date
December 18, 2028
Ianalumab
Intravenous infusion, prepared from concentrate solution
Placebo
Intravenous infusion, prepared from matching placebo
Corticosteroids
Oral or parental (if clinically justified)
Novartis Investigative Site, Vienna
Novartis Investigative Site, Caba
Novartis Investigative Site, Sofia
Novartis Investigative Site, Grålum
Novartis Investigative Site, Garran
Novartis Investigative Site, Brasschaat
Novartis Investigative Site, Leuven
Novartis Investigative Site, Melbourne
Novartis Investigative Site, Clayton
Novartis Investigative Site, San Miguel de Tucumán
Novartis Investigative Site, Plovdiv
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Wooloongabba
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Salzburg
Novartis Investigative Site, Innsbruck
Novartis Investigative Site, Bruges
Novartis Investigative Site, Roeselare
Novartis Investigative Site, George Town
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bangkok
Hematology Oncology Association of Rockland, Nyack
Clinical Research Alliance, Lake Success
Novartis Investigative Site, Caen
Novartis Investigative Site, Mexico City
Oncology Care Associates, Bethesda
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Murcia
Napa Research, Margate
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Trieste
Novartis Investigative Site, Rennes
Novartis Investigative Site, Giessen
Novartis Investigative Site, Vicenza
Novartis Investigative Site, Salamanca
Novartis Investigative Site, Bologna
Novartis Investigative Site, Seville
Cleveland Clinic Foundation, Cleveland
Novartis Investigative Site, Essen
STAT Research Inc, Dayton
Parkview Research Center, Fort Wayne
Michigan Center of Medical Research, Farmington Hills
Novartis Investigative Site, Florence
Novartis Investigative Site, Chiang Mai
Novartis Investigative Site, Samsun
Metro Minnesota CCOP, Saint Louis Park
Mayo Clinic Rochester, Rochester
Novartis Investigative Site, Morelia
Novartis Investigative Site, Lille
St Vincent Frontier Cancer Center, Billings
Novartis Investigative Site, Frankfurt am Main
Uni of Chi Medi Ctr Hema and Onco, Chicago
Novartis Investigative Site, Monterrey
Novartis Investigative Site, Kuala Selangor
Novartis Investigative Site, Le Mans
Novartis Investigative Site, Chambéry
Mays Cancer Ctr Uthsa Mdacc, San Antonio
University of Colorado Anschutz, Aurora
Novartis Investigative Site, Johor Bahru
Community Cancer Trials of Utah, Ogden
Yuma Regional Medical Center, Yuma
Compassionate Care Res Group Inc, Fountain Valley
Novartis Investigative Site, Kuching
Community Cancer Institute, Clovis
Novartis Investigative Site, Hanoi
Novartis Investigative Site, Beijing
Novartis Investigative Site, Dalian
Novartis Investigative Site, Singapore
Novartis Investigative Site, Singapore
Novartis Investigative Site, Changzhou
Novartis Investigative Site, Bengbu
Novartis Investigative Site, Rishikesh
Novartis Investigative Site, Tianjin
Novartis Investigative Site, Hangzhou
Novartis Investigative Site, Nanchang
Novartis Investigative Site, Ahmedabad
Novartis Investigative Site, Mumbai
Novartis Investigative Site, Wuhan
Novartis Investigative Site, Zhengzhou
Novartis Investigative Site, Luoyang
Novartis Investigative Site, Guangzhou
Novartis Investigative Site, Shenzhen
Novartis Investigative Site, Chengdu
Novartis Investigative Site, Kunming
Novartis Investigative Site, Kolkata
Novartis Investigative Site, Xi'an
Novartis Investigative Site, Ho Chi Minh City
Massachusetts General Hospital, Boston
Beth Israel Deaconess Med Center, Boston
Rhode Island Hospital, Providence
Novartis Investigative Site, CABA
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Caba
Novartis Investigative Site, Shijiazhuang
Novartis Investigative Site, Ostrava
Novartis Investigative Site, Brno
Novartis Investigative Site, Prague
Novartis Investigative Site, Prague
Novartis Investigative Site, Dresden
Novartis Investigative Site, Dresden
Novartis Investigative Site, Jena
Novartis Investigative Site, New Territories
Novartis Investigative Site, Hong Kong
Novartis Investigative Site, Budapest
Novartis Investigative Site, Roma
Novartis Investigative Site, Nagakute
Novartis Investigative Site, Shibukawa
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Okayama
Novartis Investigative Site, Iruma-gun
Novartis Investigative Site, Chiba
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Gifu
Novartis Investigative Site, Osaka
Novartis Investigative Site, Mexico City
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Singapore
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Aydin
Novartis Investigative Site, Birmingham
Novartis Investigative Site, London
Novartis Investigative Site, Nottingham
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY